129 related articles for article (PubMed ID: 36716281)
1. Modulating Cytotoxicity with Lego-like Chemistry: Upgrading Mitochondriotropic Antioxidants with Prototypical Cationic Carrier Bricks.
Benfeito S; Fernandes C; Chavarria D; Barreiro S; Cagide F; Sequeira L; Teixeira J; Silva R; Remião F; Oliveira PJ; Uriarte E; Borges F
J Med Chem; 2023 Feb; 66(3):1835-1851. PubMed ID: 36716281
[TBL] [Abstract][Full Text] [Related]
2. Desrisking the Cytotoxicity of a Mitochondriotropic Antioxidant Based on Caffeic Acid by a PEGylated Strategy.
Fernandes C; Benfeito S; Amorim R; Teixeira J; Oliveira PJ; Remião F; Borges F
Bioconjug Chem; 2018 Aug; 29(8):2723-2733. PubMed ID: 29965741
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative effects of mitochondria-targeted cationic antioxidants and analogs: Role of mitochondrial bioenergetics and energy-sensing mechanism.
Cheng G; Zielonka J; McAllister D; Hardy M; Ouari O; Joseph J; Dwinell MB; Kalyanaraman B
Cancer Lett; 2015 Aug; 365(1):96-106. PubMed ID: 26004344
[TBL] [Abstract][Full Text] [Related]
4. Triphenylphosphonium-conjugated glycol chitosan microspheres for mitochondria-targeted drug delivery.
Lee YH; Park HI; Chang WS; Choi JS
Int J Biol Macromol; 2021 Jan; 167():35-45. PubMed ID: 33227331
[TBL] [Abstract][Full Text] [Related]
5. Lipophilic triphenylphosphonium derivatives enhance radiation-induced cell killing via inhibition of mitochondrial energy metabolism in tumor cells.
Yasui H; Yamamoto K; Suzuki M; Sakai Y; Bo T; Nagane M; Nishimura E; Yamamori T; Yamasaki T; Yamada KI; Inanami O
Cancer Lett; 2017 Apr; 390():160-167. PubMed ID: 28093283
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria-targeted antioxidant and glycolysis inhibition: synergistic therapy in hepatocellular carcinoma.
Dilip A; Cheng G; Joseph J; Kunnimalaiyaan S; Kalyanaraman B; Kunnimalaiyaan M; Gamblin TC
Anticancer Drugs; 2013 Oct; 24(9):881-8. PubMed ID: 23872912
[TBL] [Abstract][Full Text] [Related]
7. Fine-tuning the neuroprotective and blood-brain barrier permeability profile of multi-target agents designed to prevent progressive mitochondrial dysfunction.
Benfeito S; Oliveira C; Fernandes C; Cagide F; Teixeira J; Amorim R; Garrido J; Martins C; Sarmento B; Silva R; Remião F; Uriarte E; Oliveira PJ; Borges F
Eur J Med Chem; 2019 Apr; 167():525-545. PubMed ID: 30784884
[TBL] [Abstract][Full Text] [Related]
8. Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis.
Dhanasekaran A; Kotamraju S; Kalivendi SV; Matsunaga T; Shang T; Keszler A; Joseph J; Kalyanaraman B
J Biol Chem; 2004 Sep; 279(36):37575-87. PubMed ID: 15220329
[TBL] [Abstract][Full Text] [Related]
9. Triphenylphosphonium (TPP)-Based Antioxidants: A New Perspective on Antioxidant Design.
Wang JY; Li JQ; Xiao YM; Fu B; Qin ZH
ChemMedChem; 2020 Mar; 15(5):404-410. PubMed ID: 32020724
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of Liriope platyphylla extract against hydrogen peroxide-induced cytotoxicity in human neuroblastoma SH-SY5Y cells.
Park HR; Lee H; Park H; Jeon JW; Cho WK; Ma JY
BMC Complement Altern Med; 2015 Jun; 15():171. PubMed ID: 26054856
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria-targeted nitroxides exacerbate fluvastatin-mediated cytostatic and cytotoxic effects in breast cancer cells.
Cheng G; Lopez M; Zielonka J; Hauser AD; Joseph J; McAllister D; Rowe JJ; Sugg SL; Williams CL; Kalyanaraman B
Cancer Biol Ther; 2011 Oct; 12(8):707-17. PubMed ID: 21799303
[TBL] [Abstract][Full Text] [Related]
12. Rapid uptake of lipophilic triphenylphosphonium cations by mitochondria in vivo following intravenous injection: implications for mitochondria-specific therapies and probes.
Porteous CM; Logan A; Evans C; Ledgerwood EC; Menon DK; Aigbirhio F; Smith RA; Murphy MP
Biochim Biophys Acta; 2010 Sep; 1800(9):1009-17. PubMed ID: 20621583
[TBL] [Abstract][Full Text] [Related]
13. Selective and reversible disruption of mitochondrial inner membrane protein complexes by lipophilic cations.
Kafkova A; Tilokani L; Trčka F; Šrámková V; Vancová M; Bílý T; Nebesářová J; Prudent J; Trnka J
Mitochondrion; 2023 Jan; 68():60-71. PubMed ID: 36402364
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic effects of 4'-hydroxychalcone on human neuroblastoma cells (SH-SY5Y).
de Moura Escobar SJ; Simone M; Martin N; de Oliveira Ribeiro CA; Martinez GR; Winnischofer SMB; Witting PK; Rocha MEM
Toxicol In Vitro; 2019 Dec; 61():104640. PubMed ID: 31493544
[TBL] [Abstract][Full Text] [Related]
15. Hydroxybenzoic Acid Derivatives as Dual-Target Ligands: Mitochondriotropic Antioxidants and Cholinesterase Inhibitors.
Oliveira C; Cagide F; Teixeira J; Amorim R; Sequeira L; Mesiti F; Silva T; Garrido J; Remião F; Vilar S; Uriarte E; Oliveira PJ; Borges F
Front Chem; 2018; 6():126. PubMed ID: 29740575
[TBL] [Abstract][Full Text] [Related]
16. Rational discovery and development of a mitochondria-targeted antioxidant based on cinnamic acid scaffold.
Teixeira J; Soares P; Benfeito S; Gaspar A; Garrido J; Murphy MP; Borges F
Free Radic Res; 2012 May; 46(5):600-11. PubMed ID: 22292941
[TBL] [Abstract][Full Text] [Related]
17. Micelles Loaded With Puerarin And Modified With Triphenylphosphonium Cation Possess Mitochondrial Targeting And Demonstrate Enhanced Protective Effect Against Isoprenaline-Induced H9c2 Cells Apoptosis.
Li WQ; Wu JY; Xiang DX; Luo SL; Hu XB; Tang TT; Sun TL; Liu XY
Int J Nanomedicine; 2019; 14():8345-8360. PubMed ID: 31695371
[TBL] [Abstract][Full Text] [Related]
18. Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer.
Liu HN; Guo NN; Guo WW; Huang-Fu MY; Vakili MR; Chen JJ; Xu WH; Wei QC; Han M; Lavasanifar A; Gao JQ
Acta Pharmacol Sin; 2018 Oct; 39(10):1681-1692. PubMed ID: 29849132
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria dysfunction induced by decyl-TPP mitochondriotropic antioxidant based on caffeic acid AntiOxCIN
Amorim R; Magalhães CC; Benfeito S; Cagide F; Tavares LC; Santos K; Sardão VA; Datta S; Cortopassi GA; Baldeiras I; Jones JG; Borges F; Oliveira PJ; Teixeira J
Biochem Pharmacol; 2024 Jan; 219():115953. PubMed ID: 38036191
[TBL] [Abstract][Full Text] [Related]
20. A Novel Triphenylphosphonium Carrier to Target Mitochondria without Uncoupling Oxidative Phosphorylation.
Kulkarni CA; Fink BD; Gibbs BE; Chheda PR; Wu M; Sivitz WI; Kerns RJ
J Med Chem; 2021 Jan; 64(1):662-676. PubMed ID: 33395531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
